U.C. Berkeley and the Broad Institute are fighting to control the patents on the revolutionary gene-editing technology. But there’s a lot more at stake than just who gets the credit and licensing fees.
Rigor académico, oficio periodístico
Artículos sobre Myriad Genetics
Mostrando todos artículos
Whether sequences of genetic material can be patented has been a matter of heated debate for the past decade or more. In many countries, patents have been granted for isolated gene sequences, methods of…
Millions of women in the US will have access to affordable genetic screening for cancer after the US Supreme Court ruled that a commercial company cannot patent human genes. The screening tests for mutations…
IDEAS AND OWNERSHIP: The concept of protecting ideas and innovation by legal means dates back to antiquity. But in the age of the internet and multinational business models, many of the existing laws are…
Principales colaboradores
-
Emeritus Professor of Law, University of Tasmania
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
-
Chief Executive, Institute of Cancer Research, London
-
Emeritus Professor of Paediatric Genetics, University of Bristol
-
Professor of Clinical Genetics, University of Southampton
-
Associate Professor of Public Policy and Women's Studies, University of Michigan
